Shilan Babamiri’s research while affiliated with Islamic Azad University, Tehran and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (1)


The Efficacy of Ganoderma lucidum in Overweight Individuals: A Randomized Placebo-controlled trial
  • Article
  • Full-text available

February 2022

·

403 Reads

·

4 Citations

Mediterranean Journal of Nutrition and Metabolism

Shilan Babamiri

·

·

BACKGROUND: There are growing interests in the use of medicinal mushrooms in controlling overweight and obesity. OBJECTIVE: The aim of the present study was to assess the effect of Lingzhi on anthropometric indices, fasting blood sugar, lipid profile and blood pressure of overweight individuals METHODS: This randomized double-blind clinical trial was performed on seventy-two overweight individuals (Body Mass Index (BMI) = 25–29.9 kg/m2) received 3 capsule Ganoderma Lucidum (each capsule containing 220 mg of whole powder and 30 mg of pure aqueous extract) daily or matching placebo for 6 weeks. Anthropometric indices, metabolic tests (fasting blood sugar (FBS) and serum lipid profile) and blood pressure were measured before and after treatment. RESULTS: Data analyses indicated that body weight and BMI were decreased after 6-week intervention (P < 0.05). The beneficial effect of supplementation was evident on some anthropometric indices. Changes in LDL-cholesterol were significantly different between two treatment and placebo groups (P < 0.05). FBS, other components of lipid profile and blood pressure did not significantly change by Lingzi treatment. CONCLUSIONS: Results showed that Ganoderma Lucidum might have some potential benefits on anthropometric indices and mild effects on lipid profile, but and there is no claim for weight lose function. Hence, further long-term studies are recommended.

Download

Citations (1)


... The inclusion criteria were met by a total of 13 studies, including two in MetS population [21,22], two in T2DM subjects [18,20], one in FM patient [30], six in healthy volunteer [24][25][26][27][28][29], and two suffered from CAD [19,23]. The total participants were 138, 117, 64, 134, and 133 in each group, respectively, with relatively similar male to female ratios, except for Babamiri et al. [24], Sarikaputhi et al. [29], and Pazzi et al. [30] with predominantly female respondents. ...

Reference:

Unveiling the Metabolic Effects of Ganoderma lucidum in Humans: A Systematic Review and Meta-Analysis
The Efficacy of Ganoderma lucidum in Overweight Individuals: A Randomized Placebo-controlled trial

Mediterranean Journal of Nutrition and Metabolism